Global Veterinary Biochemistry Analyzers Market Size By Type (Automatic, Semi-automatic), By Application (Pet Hospital, Veterinary Station), By Region, And Segment Forecasts, 2023 to 2032

The Global Veterinary Biochemistry Analyzers Market was valued at USD 1.1 billion in 2023 and is projected to surpass USD 2.0 billion by 2031, growing at a CAGR of 7.8% during the forecast period from 2023 to 2031. This market is driven by the rising demand for animal diagnostics, increasing pet ownership, and the growing prevalence of zoonotic and chronic animal diseases. Veterinary biochemistry analyzers are essential tools in veterinary clinics and research institutions for evaluating animal health through precise biochemical analysis of blood, serum, and plasma samples. Technological advancements, including portable and point-of-care analyzers, further boost adoption.

Drivers:

1. Increasing Pet Ownership and Livestock Population:

A global rise in pet adoption and livestock farming is significantly fueling the need for veterinary diagnostic tools. Owners and veterinarians are increasingly focusing on preventive healthcare, which is accelerating the use of biochemistry analyzers in regular animal checkups.

2. Advancements in Veterinary Diagnostic Technologies:

The integration of AI and automation into veterinary analyzers enables faster and more accurate results, improving decision-making and boosting the appeal of these systems among animal healthcare providers.

3. Rising Prevalence of Animal Diseases:

A growing incidence of diseases like diabetes, kidney disorders, and hepatic issues in animals is intensifying the demand for reliable and fast diagnostic equipment in veterinary settings.

Restraints:

1. High Equipment Costs:

Advanced veterinary biochemistry analyzers can be expensive to purchase and maintain, particularly affecting small veterinary practices and clinics in developing regions.

2. Limited Awareness and Infrastructure in Emerging Economies:

In many developing countries, limited awareness and underdeveloped veterinary healthcare infrastructure hinder market expansion despite a growing need for animal health diagnostics.

Opportunity:

1. Expansion of Point-of-Care Testing (POCT):

The shift toward portable, easy-to-use diagnostic analyzers provides significant growth opportunities, especially for use in field settings and mobile veterinary units.

2. Growth in Companion Animal Diagnostics:

With increasing pet humanization and healthcare spending, diagnostic solutions specific to companion animals are emerging as a key opportunity segment.

Market by System Type Insights:

Based on system type, the fully automated veterinary biochemistry analyzers segment dominated the market in 2023. These systems offer enhanced workflow efficiency, minimized human error, and the ability to handle high sample volumes, making them ideal for large animal hospitals and diagnostic labs. Meanwhile, semi-automated analyzers are gaining traction among small clinics due to affordability and versatility.

Market by End-use Insights:

In terms of end-use, veterinary hospitals and clinics accounted for the largest market share in 2023. These settings require accurate and timely diagnostics for effective treatment. The research institutes segment is also growing steadily due to rising investments in animal disease research and drug development.

Market by Regional Insights:

North America led the global market in 2023, supported by robust veterinary infrastructure, high pet healthcare expenditure, and early technology adoption. Asia-Pacific is projected to experience the fastest growth due to increasing livestock population, pet adoption rates, and expanding access to veterinary services in countries like China and India.

Competitive Scenario:

Key players in the global veterinary biochemistry analyzers market include IDEXX Laboratories, Heska Corporation, Zoetis Inc., Randox Laboratories, URIT Medical Electronic Co. Ltd., Abaxis Inc. (a Zoetis company), Eurolyser Diagnostica GmbH, and Mindray Animal Medical. These companies are focusing on innovation, geographic expansion, and mergers & acquisitions to strengthen market presence.

Scope of Work – Global Veterinary Biochemistry Analyzers Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031) USD 2.0 billion

CAGR (2023–2031) 7.8%

Market Segments By System Type (Fully Automated, Semi-Automated), End-Use, Region

Growth Drivers Increasing pet ownership, demand for animal diagnostics, tech advances

Opportunities Point-of-care testing, expansion in companion animal diagnostics

Key Market Developments:

June 2023: IDEXX Laboratories launched a next-gen veterinary biochemistry analyzer featuring AI integration and remote diagnostics for improved veterinary workflow.

April 2024: Zoetis Inc. introduced a compact, high-throughput analyzer specifically targeting mid-size veterinary clinics in Europe and North America.

February 2025: Heska Corporation expanded its operations into Southeast Asia, aiming to deliver portable diagnostic solutions for emerging markets.

FAQs:

1) What is the current market size of the Global Veterinary Biochemistry Analyzers Market?

The market size was valued at USD 1.1 billion in 2023.

2) What is the major growth driver of the Global Veterinary Biochemistry Analyzers Market?

The increasing demand for animal diagnostics and rising pet ownership are the primary growth drivers.

3) Which is the largest region during the forecast period in the Global Veterinary Biochemistry Analyzers Market?

North America is expected to remain the largest regional market through 2031.

4) Which segment accounted for the largest market share in the Global Veterinary Biochemistry Analyzers Market?

The fully automated veterinary biochemistry analyzers segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Veterinary Biochemistry Analyzers Market?

Key players include IDEXX Laboratories, Heska Corporation, Zoetis Inc., Randox Laboratories, and Mindray Animal Medical.